Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kos, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 59 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zavasnik-Bergant, V; Sekirnik, A; Golouh, R; Turk, V; Kos, J
      Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue

      BIOLOGICAL CHEMISTRY
    2. Zore, I; Krasovec, M; Cimerman, N; Kuhelj, R; Werle, B; Nielsen, HJ; Brunner, N; Kos, J
      Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer

      BIOLOGICAL CHEMISTRY
    3. Premzl, A; Puizdar, V; Zavasnik-Bergant, V; Kopitar-Jerala, N; Lah, TT; Katunuma, N; Sloane, BF; Turk, V; Kos, J
      Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases

      BIOLOGICAL CHEMISTRY
    4. Smith, MAJ; Dekker, R; Kos, J; Hontelez, JAM
      The availability of unmanned air vehicles: a post-case study

      JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY
    5. Strojnik, T; Zidanik, B; Kos, J; Lah, TT
      Cathepsins B and L are markers for clinically invasive types of meningiomas

      NEUROSURGERY
    6. Cimerman, N; Brguljan, PM; Krasovec, M; Suskovic, S; Kos, J
      Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    7. Cimerman, N; Brguljan, PM; Krasovec, M; Suskovic, S; Kos, J
      Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma

      CLINICA CHIMICA ACTA
    8. Kos, J; Sekirnik, A; Kopitar, G; Cimerman, N; Kayser, K; Stremmer, A; Fiehn, W; Werle, B
      Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis

      BRITISH JOURNAL OF CANCER
    9. Hashimoto, Y; Kakegawa, H; Narita, Y; Hachiya, Y; Hayakawa, T; Kos, J; Turk, V; Katunuma, N
      Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    10. Butkovic, V; Simpraga, M; Sehic, M; Stanin, D; Susic, V; Capak, D; Kos, J
      Dental diseases of dogs: A retrospective study of radiological data

      ACTA VETERINARIA BRNO
    11. Sier, CFM; Casetta, G; Verheijen, JH; Tizzani, A; Agape, V; Kos, J; Blasi, F; Hanemaaijer, R
      Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9)are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers

      CLINICAL CANCER RESEARCH
    12. Strojan, P; Budihna, M; Smid, L; Svetic, B; Vrhovec, I; Kos, J; Skrk, J
      Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck

      CLINICAL CANCER RESEARCH
    13. Kos, J; Krasovec, M; Cimerman, N; Nielsen, HJ; Christensen, IJ; Brunner, N
      Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: Relation to prognosis

      CLINICAL CANCER RESEARCH
    14. Lah, TT; Cercek, M; Blejec, A; Kos, J; Gorodetsky, E; Somers, R; Daskal, I
      Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: Comparison with cathepsin D, cathepsin L, and other clinical indicators

      CLINICAL CANCER RESEARCH
    15. Katic, V; Majstorovic, L; Maticic, D; Pirkic, B; Yin, S; Kos, J; Martinovic, S; McCartney, JE; Vukicevic, S
      Biological repair of thyroid cartilage defects by osteogenic protein-1 (bone morphogenetic protein-7) in dog

      GROWTH FACTORS
    16. Gohberg, I; Kaashoek, MA; Kos, J
      Classification of linear periodic difference equations under periodic or kinematic similarity

      SIAM JOURNAL ON MATRIX ANALYSIS AND APPLICATIONS
    17. Kos, J; Werle, B; Lah, T; Brunner, N
      Cysteine proteinases and their inhibitors in extracellular fluids: Markersfor diagnosis and prognosis in cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    18. Lah, TT; Strojnik, T; Levicar, N; Bervar, A; Zajc, I; Pilkington, G; Kos, J
      Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    19. Rinck, M; Rinck, R; Rinck, J; Sulimanovic, D; Kos, J; Janicki, Z
      Morphometric anal sac measurements in red fox (Vulpes vulpes LINNE 1758)

      ZEITSCHRIFT FUR JAGDWISSENSCHAFT
    20. Kopitar-Jerala, N; Bestagno, M; Fan, XH; Novak-Despot, D; Burrone, O; Kos, J; Skrk, J; Gubensek, F
      Molecular cloning and chimerisation of CDI 315B monoclonal antibody

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    21. Strojnik, T; Zajc, I; Bervar, A; Zidanik, B; Golouh', R; Kos, J; Dolenc, V; Lah, T
      Cathepsin B and its inhibitor stefin A in brain tumors

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    22. Cimerman, N; Brguljan, PM; Krasovec, M; Suskovic, S; Kos, J
      Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients

      CLINICA CHIMICA ACTA
    23. Cimerman, N; Brguljan, PM; Krasovec, M; Suskovic, S; Kos, J
      Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects

      CLINICA CHIMICA ACTA
    24. Werle, B; Kraft, C; Lah, TT; Kos, J; Schanzenbacher, U; Kayser, K; Ebert, W; Spiess, E
      Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma

      CANCER
    25. Schweiger, A; Staib, A; Werle, B; Krasovec, M; Lah, TT; Ebert, W; Turk, V; Kos, J
      Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking

      BRITISH JOURNAL OF CANCER
    26. Werle, B; Staib, A; Julke, B; Ebert, W; Zladoidsky, P; Sekirnik, A; Kos, J; Spiess, E
      Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts

      BIOLOGICAL CHEMISTRY
    27. Strojnik, T; Kos, J; Zidanik, B; Golouh, R; Lah, T
      Cathepsin B immunohistochemical staining in tumor and endothelial cells isa new prognostic factor for survival in patients with brain tumors

      CLINICAL CANCER RESEARCH
    28. Zrimsek, P; Kos, J; Pinter, L; Drobnic-Kosorok, M
      Detection by ELISA of the humoral immune response in rabbits naturally infected with Trichophyton mentagrophytes

      VETERINARY MICROBIOLOGY
    29. Pellegrino, A; van Beuzekom, MG; van den Born, EE; Groep, DL; Hesselink, WHA; Jans, E; Kalantar-Nayestanaki, N; Kasdorp, WJ; Kos, J; Kruszynska, MN; Kwakkel, E; van Leeuwe, JJ; Mul, FA; Onderwater, CJG; Peek, HZ; Ploegmakers, T; Poelman, A; Starink, R; Steijger, JJM; Sturris, HJ; Templon, JA; Visschers, JL; van Wijk, RF; Zwart, ANM
      Proton detection with large-acceptance scintillator detection systems in electron-scattering environments

      NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
    30. Kos, J
      More on cystatin C - Reply

      CLINICAL CHEMISTRY
    31. Cimerman, N; Brguljan, PM; Krasovec, M; Suskovic, S; Kos, J
      Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera

      CLINICA CHIMICA ACTA
    32. Werle, B; Lotterle, H; Schanzenbacher, U; Lah, TT; Kalman, E; Kayser, K; Bulzebruck, H; Schirren, J; Krasovec, M; Kos, J; Spiess, E
      Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

      BRITISH JOURNAL OF CANCER
    33. LAH TT; KOS J
      CYSTEINE PROTEINASES IN CANCER PROGRESSION AND THEIR CLINICAL RELEVANCE FOR PROGNOSIS

      Biological chemistry
    34. KOS J; NIELSEN HJ; KRASOVEC M; CHRISTENSEN IJ; CIMERMAN N; STEPHENS RW; BRUNNER N
      PROGNOSTIC VALUES OF CATHEPSIN-B AND CARCINOEMBRYONIC ANTIGEN IN SERAOF PATIENTS WITH COLORECTAL-CANCER

      Clinical cancer research
    35. KOS J; LAH TT
      CYSTEINE PROTEINASES AND THEIR ENDOGENOUS INHIBITORS - TARGET PROTEINS FOR PROGNOSIS, DIAGNOSIS AND THERAPY IN CANCER (REVIEW)

      Oncology Reports
    36. FOEKENS JA; KOS J; PETERS HA; KRASOVEC M; LOOK MP; CIMERMAN N; MEIJERVANGELDER ME; HENZENLOGMANS SC; VANPUTTEN WLJ; KLIJN JGM
      PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-B AND CATHEPSIN-L IN PRIMARY HUMAN BREAST-CANCER

      Journal of clinical oncology
    37. ZEROVNIK E; KOPITAR G; KOS J; TURK V
      REFOLDING OF RECOMBINANT SULFONATED PROCATHEPSIN-S AND OF REDUCED CHICKEN CYSTATIN - IMPLICATIONS FOR RENATURATION EXPERIMENTS

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    38. Kos, J; Stabuc, B; Cimerman, N; Brunner, N
      Serum cystatin C, a new marker of glomerular filtration rate, is increasedduring malignant progression

      CLINICAL CHEMISTRY
    39. ZEROVNIK E; CIMERMAN N; KOS J; TURK V; LOHNER K
      THERMAL-DENATURATION OF HUMAN CYSTATIN-C AND 2 OF ITS VARIANTS - COMPARISON TO CHICKEN CYSTATIN

      Biological chemistry
    40. KOS J; STABUC B; SCHWEIGER A; KRASOVEC M; CIMERMAN N; KOPITARJERALA N; VRHOVEC I
      CATHEPSIN-B, CATHEPSIN-H, AND CATHEPSIN-L AND THEIR INHIBITORS STEFIN-A AND CYSTATIN-C IN SERA OF MELANOMA PATIENTS

      Clinical cancer research
    41. SMID L; STROJAN P; BUDIHNA M; SKRK J; VRHOVEC I; ZARGI M; KOS J
      PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-D AND STEFIN-A AND STEFIN-B IN LARYNGEAL CARCINOMA

      European archives of oto-rhino-laryngology
    42. GRABAREVIC Z; TISLJAR M; ARTUKOVIC B; BRATULIC M; DZAJA P; SEIWERTH S; SIKIRIC P; PERIC J; GERES D; KOS J
      THE INFLUENCE OF BPC-157 ON NITRIC-OXIDE AGONIST AND ANTAGONIST-INDUCED LESIONS IN BROILER CHICKS

      JOURNAL OF PHYSIOLOGY-PARIS
    43. SEIWERTH S; SIKIRIC P; GRABAREVIC Z; ZORICIC I; HANZEVACKI M; LJUBANOVIC D; CORIC V; KONJEVODA P; PETEK M; RUCMAN R; TURKOVIC B; PEROVIC D; MIKUS D; JANDRIJEVIC S; MEDVIDOVIC M; TADIC T; ROMAC B; KOS J; PERIC J; KOLEGA Z
      BPC 157S EFFECT ON HEALING

      JOURNAL OF PHYSIOLOGY-PARIS
    44. KOS J; HASENFRATZ M; BATTIG K
      EFFECTS OF A 2-DAY ABSTINENCE FROM SMOKING ON DIETARY, COGNITIVE, SUBJECTIVE, AND PHYSIOLOGICAL-PARAMETERS AMONG YOUNGER AND OLDER FEMALE SMOKERS

      Physiology & behavior
    45. SCHWEIGER A; STABUC B; POPOVIC T; TURK V; KOS J
      ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF TOTAL CATHEPSIN-H IN HUMAN TISSUE CYTOSOLS AND SERA

      Journal of immunological methods
    46. KRAMAR B; PETELIN M; PAVLICA Z; KOS J; SKALERIC U
      TGF-BETA(1) CONCENTRATION IN GINGIVAL FLUID

      Journal of dental research
    47. BUDIHNA M; STROJAN P; SMID L; SKRK J; VRHOVEC I; ZUPEVC A; RUDOLF Z; ZARGI M; KRASOVEC M; SVETIC B; KOPITARJERALA N; KOS J
      PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L, CATHEPSIN-D AND THEIR ENDOGENOUS INHIBITORS STEFIN-A AND STEFIN-B IN HEAD-AND-NECK-CARCINOMA

      Biological chemistry Hoppe-Seyler
    48. GOHBERG I; KAASHOEK MA; KOS J
      THE ASYMPTOTIC-BEHAVIOR OF THE SINGULAR-VALUES OF MATRIX POWERS AND APPLICATIONS

      Linear algebra and its applications
    49. KRAMAR B; PETELIN M; PAVLICA Z; KOS J; SKALERIC U
      TGF-BETA(1) CONCENTRATION IN GINGIVAL FLUID

      Journal of dental research
    50. DOLENC I; TURK B; KOS J; TURK V
      INTERACTION OF HUMAN CATHEPSIN-C WITH CHICKEN CYSTATIN

      FEBS letters
    51. KOS J; BATTIG K
      COMPARISON OF AN ELECTRONIC FOOD DIARY WITH A NONQUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE IN MALE AND FEMALE SMOKERS AND NONSMOKERS

      Journal of the American Dietetic Association
    52. VANDONGEN MPFM; KOS J
      THE ANALYSIS OF SHIP AIR DEFENSE - THE SIMULATION-MODEL SEAROADS

      Naval research logistics
    53. KOS J; SMID A; KRASOVEC M; SVETIC B; LENARCIC B; VRHOVEC I; SKRK J; TURK V
      LYSOSOMAL PROTEASES CATHEPSIN-D, CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L AND THEIR INHIBITORS STEFIN-A AND STEFIN-B IN HEAD AND NECK-CANCER

      Biological chemistry Hoppe-Seyler
    54. TURK B; BIETH JG; BJORK I; DOLENC I; TURK D; CIMERMAN N; KOS J; COLIC A; STOKA V; TURK V
      REGULATION OF THE ACTIVITY OF LYSOSOMAL CYSTEINE PROTEINASES BY PH-INDUCED INACTIVATION AND OR ENDOGENOUS PROTEIN INHIBITORS, CYSTATINS/

      Biological chemistry Hoppe-Seyler
    55. KOS J; WOERDEMAN HJ
      HERMITIAN COMPLETIONS OF BAND MATRICES AND APPLICATIONS

      Linear algebra and its applications
    56. MALIEPAARD C; BAS N; VANHEUSDEN S; KOS J; PET G; VERKERK R; VRIELINK R; ZABEL P; LINDHOUT P
      MAPPING OF QTLS FOR GLANDULAR TRICHOME DENSITIES AND TRIALEURODES-VAPORARIORUM (GREENHOUSE-WHITEFLY) RESISTANCE IN AN F2 FROM LYCOPERSICON-ESCULENTUM X LYCOPERSICON-HIRSUTUM F-GLABRATUM

      Heredity
    57. BATTIG K; KOS J; HASENFRATZ M
      SMOKING AND FOOD-INTAKE IN A FIELD-STUDY - CONTINUOUS ACTOMETER HEART-RATE RECORDING AND POCKET COMPUTER-ASSISTED DIETARY REPORTS, SUBJECTIVE SELF-ASSESSMENTS, AND MENTAL PERFORMANCE

      Drug development research
    58. JANSE CJ; WATERS AP; KOS J; LUGT CB
      COMPARISON OF IN-VIVO AND IN-VITRO ANTIMALARIAL ACTIVITY OF ARTEMISININ, DIHYDROARTEMISININ AND SODIUM ARTESUNATE IN THE PLASMODIUM-BERGHEIRODENT MODEL

      International journal for parasitology
    59. DIECKMANN T; MITSCHANG L; HOFMANN M; KOS J; TURK V; AUERSWALD EA; JAENICKE R; OSCHKINAT H
      THE STRUCTURES OF NATIVE PHOSPHORYLATED CHICKEN CYSTATIN AND OF A RECOMBINANT UNPHOSPHORYLATED VARIANT IN SOLUTION

      Journal of Molecular Biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 03:18:59